Energy XXI Reports Fiscal 2016 Second Quarter Results and Operations Update
Feb 16, 2016 13:00 pm UTC| Business
HOUSTON, Feb. 16, 2016 -- Energy XXI (NASDAQ:EXXI) today announced financial and operating results for the three months ended December31, 2015 (fiscal 2016 second quarter), and provided an operations update. Highlights...
Envoy Group Corp Announces Key Services Agreement
Feb 16, 2016 13:00 pm UTC| Business
VALENCIA, Calif., Feb. 16, 2016 -- Envoy Group Corp.(OTC:ENVV) is pleased to announce it has signed a consulting agreement with McCarthy Consultant Services Inc. of Newmarket, Ontario. In operation for over 35 years,...
magicJack Announces Date of Fourth Quarter and Full Year 2015 Financial Results Conference Call
Feb 16, 2016 13:00 pm UTC| Business
WEST PALM BEACH, Fla. and JERUSALEM, Feb. 16, 2016 -- magicJack VocalTec, Ltd. (Nasdaq:CALL), a leading VoIP cloud-based communications company, today announced that it will report financial results for its fourth...
Highway Holdings Limited Declares Cash Dividend
Feb 16, 2016 13:00 pm UTC| Business
HONG KONG, Feb. 16, 2016 -- Highway Holdings Limited (Nasdaq:HIHO) today announced its board of directors has declared a cash dividend of $0.10 per share on the company’s common stock. The dividend will be paid on April...
Fox Factory Holding Corp. Announces Fourth Quarter and Full Year 2015 Earnings Conference Call
Feb 16, 2016 13:00 pm UTC| Business
SCOTTS VALLEY, Calif., Feb. 16, 2016 -- Fox Factory Holding Corp. (Nasdaq:FOXF) ("FOX" or the “Company”) will announce results for the fourth quarter and full year ended December 31, 2015, on Monday, February 29, 2016,...
Quantum Materials to Present at ROTH Investment Conference
Feb 16, 2016 13:00 pm UTC| Business
SAN MARCOS, Texas, Feb. 16, 2016 -- Leading North American quantum dot manufacturerQuantum Materials Corp(OTCQB:QTMM) today announced the company will be participating in two significant events in March; the 28th Annual...
Detailed Results From SUPPRESS Trial of Brincidofovir to be Presented at BMT Tandem Meetings
Feb 16, 2016 13:00 pm UTC| Business
DURHAM, N.C., Feb. 16, 2016 -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that detailed results from the Company’s Phase 3...